Key facts
- Paul Alloway has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $1,483.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Paul Alloway
- Location
- Bedford, MA
- Summary
- The estimated net worth of Paul Alloway is at least $1,483 dollars as of 23 Apr 2024. Paul Alloway is the Former President and Chief Operating Officer of Homology Medicines, Inc. of Q32 Bio Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $1.5K.
- Signature
- /s/ Paul Alloway
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Paul Alloway and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: Q32 Bio Inc. ($1,483).
- Past-year value change for that position: .
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Paul Alloway
QTTB
Forms 3/4/5
Q32 Bio Inc.
- Holdings value
- $1,483
- Past year net change
- Change %
- Report period
- 25 Mar 2024
Insider Transactions Reported by Paul Alloway:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.